InnoCare and Lilly Sign $3.35B Drug Discovery Deal
Beijing, China, September 24, 2026 InnoCare Pharma has entered into a strategic research collaboration and license agreement with Eli...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Beijing, China, September 24, 2026 InnoCare Pharma has entered into a strategic research collaboration and license agreement with Eli...
Singapore, September 21, 2026 Specialised Therapeutics (ST) has expanded its existing partnership with Incyte to include ruxolitinib cream (Opzelura®)...
PARIS, France — September 14, 2026 Sanofi and Cheplapharm announced plans to create a new strategic partnership under which...
Mumbai, India and Warren, New Jersey, USA, September 3, 2026 Cipla Limited, through its wholly owned subsidiary InvaGen Pharmaceuticals...
Beijing, China & Florence, Italy, September 3, 2026 Gan & Lee Pharmaceuticals and The Menarini Group have entered into...
SHANGHAI, China, July 8, 2026 OTR Therapeutics and LG Chem Life Sciences have announced a strategic collaboration to accelerate...
SAN DIEGO & MELBOURNE, Australia, June 24, 2026 LENZ Therapeutics has significantly expanded the international commercialization strategy for its...
SHANGHAI, June 23, 2026 Abbisko Therapeutics Co., Ltd. announced a strategic research collaboration and license agreement with Eli Lilly...
SEOUL, South Korea, June 1, 2026 Hanmi Pharm. Co., Ltd. has entered into a landmark global licensing agreement with...
SEOUL, SOUTH KOREA | January 27, 2026 — Hanmi Pharmaceutical, the core operating company of Hanmi Science, announced a...
